Picard Medical Inc. stocks have been trading up by 33.09 percent following impactful news likely signaling strong growth prospects.
Click Here for a Millionaire's POV on Trading PMI
SUBSCRIBE FOR ALERTSJOIN 50,000+ ACTIVE TRADERS
Key Takeaways
- Shares of Picard Medical Inc. (PMI) have faded from the $5 area to the low $3s, signaling heavy selling after a recent spike.
- Daily PMI charts show sharp intraday swings, with 5-minute candles printing wide ranges that active traders can exploit but must manage carefully.
- Financials reveal roughly $4.9M in annual revenue but deep losses and negative cash flow, keeping PMI firmly in high-risk territory.
- The PMI balance sheet carries modest equity and meaningful liabilities, suggesting limited room for error if the company cannot tighten operations.
Live Update At 07:47:13 EDT: On Monday, August 24, 2026 Picard Medical Inc. stock [NYSE American: PMI] is trending up by 33.09%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.
Quick Financial Overview
PMI is trading like a classic speculative small-cap: fast moves, thin margins, and big losses. On the income side, Picard Medical Inc. pulled in about $4.94M in revenue, but the story turns ugly below the top line. Gross margin sits near 18.6%, which is low for a medical name and leaves very little cushion once operating costs hit.
The latest quarterly report for PMI shows total revenue of about $2.95M but a net loss of roughly $5.66M. That works out to about -$3.05 per share in earnings. EBITDA is deeply negative, and profit margins are more than -400% on several measures. PMI is burning cash, not generating it.
More Breaking News
- DK Surges As Delek US Earnings Smash Wall Street Targets
- Southern Copper Stock Stays Hot After Q2 Earnings Beat
- PMI Stock Slides as Losses Mount and Volatility Spikes
- ACHR Stock Jumps As Archer Aviation Strikes Major Boeing Deal
On the balance sheet, Picard Medical Inc. lists around $9.17M in total assets against $7.45M in total liabilities. Cash is thin at about $38,000 while inventory sits near $5.97M, tying up working capital. The current ratio is roughly 1, which is just break-even on short-term flexibility. For traders, PMI is not a stable earnings machine; it is a high-volatility, turnaround-style chart driven more by sentiment and momentum than fundamentals.
Why Traders Are Watching PMI Price Action
The chart is where PMI really speaks to active traders. Picard Medical Inc. ran as high as $5.13 on 2026/08/03 and $4.90 on 2026/08/04, then started a steady fade. By 2026/08/21, PMI closed at $3.21 after dipping as low as $2.65 earlier in the day. That’s a big retrace from the prior spike, showing how quickly momentum can unwind in this name.
Intraday, PMI’s 5-minute chart tells an equally wild story. Pre-market and early-session candles bounce between roughly $4.30 and $5.11, with several bars showing $0.20–$0.40 ranges in minutes. That kind of action screams day-trader playground. Breakouts and breakdowns happen fast, and liquidity can disappear just as fast. Picard Medical Inc. often tests both ends of its intraday range, which punishes anyone who chases without a plan.
From a technical view, PMI has shifted from a breakout pattern near $5 into a clear downtrend, with lower highs from $5.13 to mid-$4s and then to the low $3s. The failed push toward $4.30–$4.60 intraday, followed by closes in the low $3s, shows selling into strength. For many short-term traders, PMI is now a “fade the spikes” type chart until it proves otherwise. For dip buyers, any bounce must be treated as a trade, not a long-term conviction, given the weak fundamentals.
Conclusion
Picard Medical Inc. sits at the intersection of ugly fundamentals and exciting charts. Revenue is real, but PMI’s losses are massive and ongoing, with negative operating cash flow and razor-thin liquidity. The balance sheet shows limited cash, chunky inventories, and just enough working capital to operate, not to relax. That leaves PMI heavily dependent on capital markets or operational improvement down the road.
On the other side, the tape is alive. PMI has already shown traders it can run from the $3s into the $5s and then unwind just as fast. Those are the types of moves momentum traders study every night. The key with Picard Medical Inc. is discipline: clear setups, tight risk, and zero hesitation to cut when the pattern cracks.
Tim Sykes pounds this into students: “The market doesn’t care about your opinion. It rewards preparation, discipline, and the ability to cut losses quickly.” As Tim Bohen, lead trainer with StocksToTrade says, “For me, trading is more about managing risk than finding the next big mover.”. PMI is a textbook case for that mindset. Treat Picard Medical Inc. as a trading vehicle, not a story stock. Map the key levels on the daily and intraday charts, size small, and let the price action — not hope — drive every decision. This is educational, research-focused trading, not a substitute for your own due diligence.
This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.
Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.
Check out our quick startup guide for new traders!
- How to Read Stock Charts: A Guide for Beginners
- Trading Plan: 6 Steps to Create One
- How To Create a Stock Watchlist
Ready to build your watchlists? Check out these curated lists:
Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

